On this "Face the Nation with Margaret Brennan" broadcast, National Security Adviser Mike Waltz and Rep. Rand Paul join ...

Google Cloud today announced new AI products, as well as initiatives and skills training for the United Kingdom at an exclusive "Gemini for the United Kingdom" event held at Google DeepMind's London ...

The Taoiseach has begun his visit to the United States with a trip to Austin, a good place to feel the economic links ahead ...

Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai ...

Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President ...

And supporting Ukraine while building homegrown defenses could take the type of rapid action and united political will ... the development of new tests, therapeutics and vaccines.

Check Out Our Latest Analysis on United Therapeutics United Therapeutics Stock Down 1.6 % UTHR stock opened at $313.60 on Wednesday. United Therapeutics has a 52-week low of $221.53 and a 52-week ...

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts ...

United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The business’s fifty day moving average price is $349.12 and its 200 day moving average price is $358.27.

United Therapeutics (UTHR) came out with quarterly earnings of $6.19 per share, beating the Zacks Consensus Estimate of $6.10 per share. This compares to earnings of $4.36 per share a year ago.